Maiti A, MBBS, DiNardo CD, MD, MSCE, Rausch CR, PharmD, Pemmaraju N, MD, Garcia-Manero G, MD, Ohanian M, DO, Daver N, MD, Issa GC, MD, Borthakur G, MD, Ravandi F, MBBS, Alvarado Y, MD, Kadia TM, MD, Short NJ, MD, Jabbour EJ, MD, Montalban-Bravo G, MD, Jain N, MD, Kornblau SM, MD, Masarova L, MD, Wierda WG, Sasaki K, MD, PhD, Takahashi K, MD, PhD, Yilmaz M, MD, Burger JA, MD, PhD, Estrov ZE, MD, Verstovsek S, MD, PhD, Andreeff M , MD, PhD, Bose P, MD, Ferrajoli A, MD, Thompson PA, Montalbano K, Vaughan K, RN, Bivins CA, RN, Pierce SA, BSN, BA, Qiao W, PhD, Ning J, Welch J, PhD MD, Kantarjian H, MD, Konopleva M, MD, PhD
Cost Optimization : Peptides can be expensive
Depressive symptoms were measured before and after treatment using the GRID-Hamilton Depression Rating Scale, a standard depression assessment tool, in which a score of 24 or more indicates severe depression, 1723 moderate depression, 816 mild depression and 7 or less no depression
The reality is more nuanced: cells can reassemble glutathione from the absorbed amino acids (especially cysteine), so oral glutathione may raise body stores indirectly even if little intact tripeptide is absorbed
Epithalon is not the right protocol for every patient who asks about it
